Spots Global Cancer Trial Database for Accelerated Enhanced RECOVERy Following Minimally Invasive Colorectal Cancer Surgery (RecoverMI)

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Accelerated Enhanced RECOVERy Following Minimally Invasive Colorectal Cancer Surgery (RecoverMI)

Official Title: Accelerated Enhanced RECOVERy Following Minimally Invasive Colorectal Cancer Surgery (RecoverMI)

Study ID: NCT02613728

Conditions

Colorectal Cancer

Interventions

Accelerated Recovery Plan

Early Discharge

Telemedicine

Standard Enhanced Care

Study Description

Brief Summary: The goal of this clinical research study is to learn if RecoverMI care can help to shorten the time that patients are in the hospital after surgery and if it can help them recover sooner. RecoverMI includes the following parts: * Preoperative Education * Early oral intake * Early mobilization * Telemedicine

Detailed Description: Study Groups: If you are found to be eligible to take part in this study, you will be randomly assigned (as in the flip of a coin) to 1 of 2 study groups. This is done because no one knows if one group is the same, better, or worse than the other group. * If you are assigned to Group 1, you will receive standard enhanced care after your surgery. * If you are assigned to Group 2, you will receive routine care after surgery, but you will also receive accelerated recovery, early discharge, and Telemedicine. Participants will be loaned an iPad to use for video-conferencing and text messaging in this study. This is an investigational study. The study doctor can explain how RecoverMI is designed to work. Up to 32 participants will be enrolled in this study. All will take part at MD Anderson.